Journal Home
Search for

Volume 4, Issue 2, Pages 176-182 (June 2010)


View previous. 10 of 21 View next.

Pregnancy and IBD treatment: This challenging interplay from a patients' perspective

R.E. MountifieldabcCorresponding Author Informationemail address, R. Prossera, P. Bamptonab, K. Mullera, J.M. Andrewsbcd

Received 31 July 2009; received in revised form 2 October 2009; accepted 4 October 2009. published online 07 December 2009.

Abstract 

Introduction

Current data suggest that exacerbations of Inflammatory Bowel Disease (IBD) during pregnancy worsen perinatal outcomes. However, patients' perceptions regarding the interaction between pregnancy and IBD management are unexplored.

Aims

To (1) obtain pregnancy outcome data from local female IBD patients, and (2) to gain insight into patients' understanding of the interaction between IBD and pregnancy, and how this affects medication-taking behaviour.

Methods

Female IBD subjects aged 18–50years were surveyed by questionnaire. This large retrospective study sought patient who reported pregnancy outcomes and examined the relationship between major adverse outcomes, IBD activity and treatment. Subjective data regarding patients' perceptions about IBD management and pregnancy were sought.

Results

219 females were surveyed, 143 completing a questionnaire (68.1%). 342 pregnancies occurred, 298 of which outcome data were available. Overall IBD women reported adverse pregnancy outcome rates comparable to the local population. Major adverse outcomes were more frequent in the subgroup with severe disease during pregnancy (5/14 (35.7%)) than those with inactive disease (14/284 (4.9%)), (OR 6.8 (95% CI 1.7–26.3), p=0.006). Adjusting for disease severity, neither corticosteroid, azathioprine nor 5ASA affected pregnancy outcome. Most female patients (84%) reported (unwarranted) concerns about the effect of IBD medications on pregnancy, free text responses indicating that this was of greater concern than any effect of IBD exacerbation.

Conclusions

Unwarranted fear of adverse medication effect on pregnancy is highly prevalent in women with IBD, yet awareness of the harmful effect of IBD exacerbation during pregnancy is poor. This information gap between patients and their gastroenterologists warrants attention.

a Dept of Gastroenterology and Hepatology, Flinders Medical Centre, Australia

b Faculty of Medicine, Flinders' University, Australia

c Dept of Gastroenterology and Hepatology, Royal Adelaide Hospital, Australia

d School of Medicine, University of Adelaide, Australia

Corresponding Author InformationCorresponding author.

PII: S1873-9946(09)00106-8

doi:10.1016/j.crohns.2009.10.001


View previous. 10 of 21 View next.